ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
4676	Centers for Disease Control and Prevention	Html	en	CDC - CMV: Congenital CMV Infection	Signs of congenital CMV infection, prevention, treatment for babies born with CMV infection	citomegalovirus 0.307641 congenital cmv infection 0.920662 antivirals 0.312903 regular hearing checks 0.361005 pregnancy loss 0.329172 Español 0.309607 death 0.306638 urine 0.307125 reactivation 0.309556 Page 0.306656 babies 0.447896 virus 0.315016 Bebés nacidos 0.339129 loss 0.330615 signs 0.363482 cytomegalovirus 0.310208 variety 0.306847 pregnant woman 0.333693 long-term health problems 0.410732 first-time infection 0.373235 additional services 0.331917	Women 0.307078 baby’s saliva 0.331633 reinfection 0.306862 baby’s doctor 0.330103 childhood 0.306305 newborn hearing test 0.362157 pregnancy 0.329467 birth 0.367339 infancy 0.307705 infected babies 0.352423 different CMV strain 0.439555 blood 0.313943 infección 0.307637 previous infection 0.372019 health problems 0.478337 Medicines 0.306412 baby 0.362717 placenta 0.308353 congénita por CMV 0.456766 care 0.306241	CLICK HERE
4758	Centers for Disease Control and Prevention	Html	en	The influence of school policies on smoking prevalence among students in grades 5-9, Canada, 2004-2005.	null	smoking rates 0.613346 student smoking 0.667689 overall smoking prevalence 0.581228 school tobacco policies 0.658572 higher smoking prevalence 0.605547 smoking status 0.72369 smoking prohibition 0.600377 health region smoking 0.577444 school tobacco policy 0.550785 school smoking policies 0.890673 student smoking status 0.603064 smoking uptake 0.557574 adolescent cigarette smoking 0.541607 student smoking rates 0.561705 lower school smoking 0.608203 Youth Smoking Survey 0.646096 smoking behavior 0.71933 smoking control policies 0.574615 individual smoking behavior 0.579039 clear smoking rules 0.546929 smoking prevalence 0.888648 smoking attitudes 0.546378 higher school smoking 0.598658 Manske S. Smoking 0.542952	adolescent smoking behaviours 0.541302 adolescent smoking 0.554951 mean smoking prevalence 0.581197 school smoking policy 0.671156 smoking 0.943614 student smoking behavior 0.569027 smoking varies 0.548819 smoking behaviors 0.638579 higher smoking rates 0.552159 smoking bans 0.558719 Santana Y. Smoking 0.539808 school policies 0.570853 smoking policy characteristics 0.574717 student smoking behaviors 0.593737 youth smoking behavior 0.551939 individual smoking status 0.689987 youth smoking trajectories 0.548964 youth smoking 0.648009 tobacco policy 0.61486 lower smoking rates 0.55058 school smoking prevalence 0.880344 lower smoking prevalence 0.622049 tobacco control 0.62205 youth cigarette smoking 0.546137	CLICK HERE
6138	Centers for Disease Control and Prevention	Html	en	First World Trade Center Scientific and Medical Review Released - Media Statement: July 25, 2011	CDC Urges: Stay Cool to Stay Healthy As Temperatures Soar	cancer studies 0.507271 medical evidence 0.531288 James Zadroga 0.40981 CDC 0.3234 Sept.11 0.320271 medical findings 0.532134 rule 0.31761 determination 0.321041 occurrence 0.318176 type 0.319857 updates 0.31756 new research 0.409852 responders 0.325587 current absence 0.430847 Occupational Safety 0.428443 WTC Health Program 0.548283 New York City 0.519294 World Trade Center 0.9249 U.S. DEPARTMENT 0.407282 causal association 0.624054 Center Program Administrator 0.505709 peer-reviewed literature 0.420174	Compensation Act 0.409621 List 0.319818 review discusses criteria 0.502951 periodic reviews 0.458082 Health Program 0.604888 summary 0.320384 scientific evidence 0.425562 website 0.317248 WTC exposures 0.498793 NIOSH 0.33008 researchers 0.317548 WTC-Related Health Conditions 0.524875 9/11 0.318343 survivors 0.317742 provision 0.318725 periodic review 0.786154 WTC Administrator John 0.5774 issuance 0.324718 HUMAN SERVICES 0.407091 information 0.317297 time 0.319772	CLICK HERE
8188	Centers for Disease Control and Prevention	Html	en	Birth Defects, Facts about Gastroschisis - NCBDDD	CDC works to identify causes of birth defects and opportunities to prevent them. By applying a public health approach incorporating three essential elements—surveillance or disease tracking, research to identify causes, and prevention research and programs—we can rapidly translate scientific findings into appropriate public health interventions.	Defects Prevention Network. 0.370638 baby’s body 0.274433 Birth Defects Study 0.331326 baby’s intestines 0.246766 abdominal wall 0.307513 United States 0.212988 national birth prevalence 0.240784 Prevention Network.  Prevalence 0.213601 birth defects 0.951694 Birth Defects Prevention 0.693718 National Birth Defects 0.829697	gastroschisis defect 0.370869 Birth Defects Research 0.3252 belly button 0.297491 Disease Control 0.213646 Defects Prevention Study 0.434437 MMWR morb Mortal 0.200762 Prevention Network.   Increasing 0.206904 gastroschisis 0.69158 abdominal organs 0.247131 Defects Prevention Network 0.292244 et al. 0.204467	CLICK HERE
10073	Centers for Disease Control and Prevention	Html	en	NIOSH Program Portfolio : Dermal Diseases : Projects	The mission of the NIOSH research program for Immune, Dermal & Infectious Diseases is to eliminate occupational injuries, illnesses, and fatalities among workers in these industries through a focused program of research and prevention. Primary efforts are focused on hazard identification since when potential hazards are recognized, work-related dermal and immune diseases can often be prevented or their effects minimized.	Information Division component 0.347294 significant dermal effects 0.466903 exposure assessment methods 0.338725 exposure assessment 0.344485 dermal toxicity 0.389146 hazardous chemicals 0.360768 Occupational Research Agenda 0.413707 NORA DERP 0.375341 additional dermal hazards 0.428092 new project leadership 0.362821 chemicals 0.375333 deleterious dermal exposures 0.425901 Health Effects Laboratory 0.679831 systemic toxicity 0.344249 allergic skin sensitization 0.346225 occupational skin disease 0.347299 dermal program 0.39386 Dermal Exposure Research 0.597586 health effects 0.733804 Effects Laboratory Division 0.683367 toxic chemicals 0.363664 Information Division 0.449708 dermal penetration 0.375003 Project contact 0.907172	NIOSH Research Projects 0.38254 Project period 0.939514 Dermal Resource Guide 0.473748 dermal risk management 0.411171 adverse health effects 0.626394 Dermal Cross-Sector Team 0.430647 new skin notations 0.348724 Scott Dotson 0.51624 chemical protective clothing 0.366759 dermal exposures 0.43252 National Occupational Research 0.417897 dermal application 0.378133 occupational skin diseases 0.377595 skin notations 0.601948 allergic contact dermatitis 0.459626 occupational skin exposures 0.440595 Exposure Research Program 0.45321 NIOSH technical document 0.341732 new NIOSH strategy 0.336171 dermal exposure 0.690979 occupational dermal exposure 0.571479 Gary S. Dotson 0.396733 forth NIOSH policies 0.353617 improved skin notations 0.344399	CLICK HERE
10659	Centers for Disease Control and Prevention	Html	en	Quality of Worklife Questionnaire - NIOSH Workplace Safety and Health Topic	null	worker health 0.468837 Health Outcomes 0.396971 Work/family 0.247603 Job level 0.385627 questions 0.271326 following list 0.380511 QWL module 0.521947 layoffs 0.249762 module categories 0.504072 Employment Survey 0.403646 new items 0.412704 interagency agreement 0.43751 Worklife module 0.72762 risk factors 0.383569 primary goals 0.399092 NIOSH 0.315878 special module 0.57044 Fall/Winter 0.330808 work organization issues 0.61694 earlier Quality 0.413851 work life 0.598684 persons 0.266907 worker autonomy 0.485936 job security 0.405628 items 0.463916	Secondary goals 0.389906 worker well-being 0.475978 job satisfaction/stress 0.405443 personal interview data 0.554828 future surveys 0.397154 safety preventive interventions 0.565329 General Social Survey 0.905669 personal interview survey 0.606323 Employment Surveys 0.394268 National Science Foundation 0.909279 modifications 0.257292 wide assortment 0.418849 external expert teams 0.598144 Opinion Research Center 0.60244 25-year period 0.422499 work experience 0.413581 workload 0.245474 job/organizational characteristics 0.39899 personal interview 0.609139 worker responses 0.496584 U.S. households 0.43075 final dataset 0.402943 small group process 0.606083 Worklife Questionnaire 0.460581	CLICK HERE
10857	Centers for Disease Control and Prevention	Html	en	Current Tobacco Use and 27 Exposure Among Women of Reproductive Age — 14 Countries, 2008–2010	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	country 0.459479 traditional tobacco products 0.497463 highest prevalence 0.476621 High tobacco smoking 0.542032 higher smoking prevalence 0.530371 tobacco cessation 0.478322 current pregnancy status 0.465689 overall SHS exposure 0.556952 reproductive-aged women 0.788401 rural areas 0.475487 study countries 0.458683 middle-income countries 0.491561 female reproductive-aged respondents 0.467624 current tobacco users 0.511674 high smoking prevalence 0.516814 countries 0.552368 data collection method 0.45823 India 0.469989 female respondents ages 0.459995 important role 0.453874 tobacco products 0.50127 SHS exposure 0.900213 adverse reproductive health 0.463893 multistage cluster sample 0.457108 Regional Office 0.467349	overall tobacco prevalence 0.563947 tobacco control strategies 0.50109 current smoking prevalence 0.581711 total fertility rates 0.452966 tobacco smoking prevalence 0.728685 Russia 0.46037 fetal growth restriction 0.459214 tobacco indicators 0.484493 tobacco exposure data 0.535663 smoking initiation 0.471837 effective tobacco control 0.500573 Global Adult Tobacco 0.523218 reproductive age 0.513133 sample design 0.453972 key tobacco control 0.514728 urban areas 0.483242 high prevalence 0.478854 novel tobacco products 0.497401 home 0.469786 current tobacco smoking 0.763244 Bangladesh 0.477838 low prevalence 0.513389 tobacco smoking prevalences 0.518785 current smokeless tobacco 0.736066	CLICK HERE
11676	Centers for Disease Control and Prevention	Html	null	Preventing Chronic Disease | National and State Cost Savings Associated With Prohibiting Smoking in Subsidized and Public Housing in the United States - CDC	Despite progress in implementing smoke-free laws in indoor public places and workplaces, millions of Americans remain exposed to secondhand smoke at home. The nation’s 80 million multiunit housing residents, including the nearly 7 million who live in subsidized or public housing, are especially susceptible to secondhand smoke infiltration between units.			CLICK HERE
11791	Centers for Disease Control and Prevention	Html	en	Developing an Incident Management System to Support EbolaResponse - Liberia, July-August 2014	On October 14, 2014, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).	CDC 0.468908 Ebola infection 0.433631 organizational structure 0.473879 Social Welfare 0.465174 deputy IM 0.572226 action items 0.510503 Ebola response structure 0.588798 Zoonotic Infectious Diseases 0.531373 Ebola response framework 0.62378 initial response structure 0.497936 response structure 0.662349 emergency response 0.436612 World Health Organization 0.44791 Global Health 0.464261 MOHSW 0.582739 public health activities 0.452091 public health emergencies 0.458726 national IMS 0.446979 IMS 0.489417 response section chairs 0.467555 national Ebola response 0.556146 key Ebola response 0.545239 minister/chief medical officer 0.497154 public health response 0.527527	deputy health minister 0.472424 public health agencies 0.454258 national coordinator 0.563033 IMS general staff 0.468363 county-level response 0.432963 Ebola virus disease 0.498252 health care infrastructure 0.458451 Ebola epidemic 0.541174 Satish K. Pillai 0.517095 national task force 0.623505 public health responsibilities 0.454033 national response 0.525914 public health 0.735188 deputy health minister/chief 0.56071 Global Health Protection 0.437898 external partners 0.438534 Ebola response 0.911008 Public Health Preparedness 0.440416 Liberia 0.445639 MOHSW response structure 0.522905 national response structure 0.511482 scientific response section 0.652523 IMS structure 0.434411 non–Ebola-related public health 0.537339	CLICK HERE
13685	Centers for Disease Control and Prevention	Html	en	Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014	Gavin B. Grant, MD1; Susan E. Reef, MD1; Alya Dabbagh, PhD2; Marta Gacic-Dobo, MSc2; Peter M.	rubella epidemiology 0.405312 Western Pacific Region 0.512727 rubella control 0.478845 RCV dose 0.48152 rubella virus 0.590442 CRS cases 0.434052 rubella vaccine introduction 0.484755 rubella vaccination programs 0.459737 RCV introduction guidance 0.432442 rubella vaccination 0.470274 rubella 0.964539 endemic rubella virus 0.453605 routine immunization services 0.419678 World Health Organization 0.352914 Gavi Alliance 0.369334 countries 0.746949 Rubella Strategic Plan 0.501686 Rubella Initiative partners 0.558368 national immunization schedules 0.366905 rubella virus transmission 0.522598 rubella vaccination coverage 0.465524 congenital rubella syndrome 0.501469 regional rubella 0.415892 CRS surveillance results 0.359128	RCV 0.823352 CRS 0.579417 south-east asia region 0.423418 CRS control activities 0.364977 rubella elimination goals 0.48935 rubella elimination goal 0.485934 High-quality rubella 0.411558 rubella surveillance data 0.459629 rubella vaccine 0.533474 monovalent rubella vaccine 0.493319 RCV introduction 0.568932 rubella cases 0.679638 Vaccine Action Plan 0.458306 Action Plan rubella 0.481459 RCV coverage 0.392705 European Region 0.368291 Joint Reporting Form 0.354414 CRS control 0.445073 CRS surveillance 0.517003 Global Vaccine Action 0.455014 CRS elimination goals 0.524259 immunization schedules 0.377927 elimination goals 0.570001 future RCV introductions 0.423226	CLICK HERE